Navigation Links
Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
Date:5/21/2008

CPF and ATS to Jointly Award $200,000 in research funding

TORONTO, May 21 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) and the American Thoracic Society (ATS), the world's leading professional organization for pulmonary, critical care and sleep physicians, today announced the expansion of their research partnership in pulmonary fibrosis. CPF and ATS are making available two new two-year, $100,000 awards for researchers in the United States pursuing new approaches to understand and treat pulmonary fibrosis.

"We'd like to express our gratitude to ATS for continuing a clinical partnership that is desperately needed in the research community to make new funds available to investigators dedicated to improving our understanding of IPF," said Marvin Schwarz, MD, James C. Campbell Professor of Pulmonary Medicine, Division of Pulmonary Sciences and Critical Care Medicine University of Colorado Denver and Chairman of the CPF Board of Directors.

ATS/CPF research awards are selected through a rigorous peer-review application process administered by ATS. Awards are selected from a series of applicants who submitted proposals in the areas of basic, clinical, genetic, and translational research that focus on identifying new approaches to understand or treating pulmonary fibrosis. The letter of intent deadline for the 2008 awards is 11:59 p.m. Eastern Time Wednesday, June 25, 2008 and the award recipients will be announced in December, 2008.

"We are proud to be able to match grants in this important area of research," said Thomas R. Martin, M.D., past president of ATS and Co-Chair of the ATS Research Program with Sharon Rounds. "The ATS continues its commitment to work with nationally recognized organizations like the CPF who are dedicated to advancing lung disease research."

The ATS/CPF Partnership Grant for Pulmonary Fibrosis was established in 2006. The first grant through this partnership was a $100,000, tw
'/>"/>

SOURCE Coalition for Pulmonary Fibrosis
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Agendia Joins the Personalized Medicine Coalition (PMC)
2. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
3. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
4. FrontPath Health Coalition To Lead Community-wide Group in Pilot Program
5. Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
6. Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story
7. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
8. Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology
9. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
10. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
11. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SARASOTA, Fla., Dec. 1 Exp...Osprey Biotechnics Inc. of Sarasota has appointed ...butor. ,, Lake is located near Birmingham, Eng... bacteria which serve the agricultural, waste wate...d to be hungry and to open drain fields, and clean...
(Date:12/1/2009)... EpiVax, Inc. today announced a... RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax...ould potentially reduce detrimental immune respons...iVax collaboration, the EpiVax Tregitope technolog...enicity of protein therapeutics. , ...
(Date:12/1/2009)... , HUNTINGTON BEACH, California and AM...ld leader in molecular cancer diagnostics, announc...dicare administrator, has established,coding guide...t is Agendia,s,FDA-cleared breast cancer recurrenc...2008. , Patients across the United States...
(Date:12/1/2009)..., NEW YORK and MONTREAL, Dec. 1 /PRNewswire-Fir...er -ICBS Ltd. (OTCPK: ICBT), announced today that ...anufacturing Inc., of Canada for the manufacturing...ribution in the U.S. ,, "We have seen the disas...resh vegetables and packaged salads in the past" s...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...SULTS, VANCOUVER, Oct. 25 /PRNewswire-FirstCall/ ...TSX: ANP), a global specialty pharmaceutical and,m... discussing its,financial results for the third qu...ember 1, 2007 at 11:00 AM ET, (8:00 AM Pacifi...information is as follows:, North America (to...
...AACR-NCI-EORTC International Conference on M...ancisco, QUEBEC CITY, Oct. 25 /PRNewswire-FirstCa...S), a global biopharmaceutical company focused on,... abstract outlining novel,data generated from thre...eted cytotoxic candidates at the AACR-NCI-EORTC In...
... Therapeutics,Inc. (OTC Bulletin Board: NILT.OB) w...lthcare Conference at 10:30 AM EST on Wednesday, N...Peter Strumph, Chief Executive Officer of Nile wil... clinical development programs,including data from...ead,compound, CD-NP, a novel chimeric peptide for ...
Other Biology Technology:Notice of Conference Call and Webcast 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 3AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 4Nile Therapeutics to Present at the Rodman & Renshaw 9th Annual Healthcare Conference 2
(Date:12/2/2009)... are reporting the first identification of substan... that changes harmless marine bacteria into killer...s in ACS, Environmental Science & Technology , a ...es note that bleaching already has destroyed up to...ists are searching for ways to slow or stop the da...
(Date:12/2/2009)...led nanotubescylinders of carbon about a nanometer...applications such as ultrastrong fibers, electrica...components for fuel cells. Thanks to a new develop...tandards and Technology (NIST) and five partners, ...ction and destruction of an aggressive form of bre...
(Date:12/2/2009)...009) HOBOKEN, NJ According to the National Insti...ans diagnosed with diabetes already have some stag...damage to the retina caused by leaky blood vessels...betes and is one of the most feared diabetic compl...ts who,ve had diabetes for 10 years or more will e...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3Cervical Cancer Vaccine Not Just for Teens 47617 1Cervical Cancer Vaccine Not Just for Teens 47617 2I SPY trial offers key insights into locally advanced breast cancer 47614 1I SPY trial offers key insights into locally advanced breast cancer 47614 2I SPY trial offers key insights into locally advanced breast cancer 47614 3More stringent evaluation on the use of generic medications in thoracic transplantation 47611 1More stringent evaluation on the use of generic medications in thoracic transplantation 47611 2
...ers at CSIRO Livestock Industries, Australian Anim...epartment of Primary Industries Victoria ?are inve...g the introduced fish. , Project leader Dr Mark C... in 1998*, caused mass mortalities in carp in the ...onesia. So far the virus does not appear to have r...
...ed immune response resulting from HIV infection ca...a, according to a new study appearing in the Oct. ... available online. , "Our study demonstrates that ...epresent, next to children and pregnant women, an ...n-Pierre Van geertruyden, MD, MSc, lead author of ...
...as 18 percent of adults who have no history of str...ke, according to results of a large national study...nternal Medicine, one of the JAMA/Archives journal...hout a history of stroke reveals that many have ha...ckground information in the article. One previous...
Other Biology News:Virus may control Australia's 2Malaria treatment efficacy compromised in certain HIV-positive patients 2Stroke symptoms common among general population 2
...6820 GC system combines world-class performance ha...QA/QC software, Agilents world-renowned support an...and supplies--a combination that lets you reach un...sions based on dependable data. The Agilent 6820 G...
...PolarScreen Peroxisome Proliferator-Activated Rece...de a sensitive and efficient method for studying a...orescence polarization (FP). The kit contains huma...with an N-terminal His-tag and a novel, selective ...
...MSQ™ Plus is a small and sensitive single q...d IC. It features a newly designed self-cleaning t...API) source for outstanding sensitivity and noise ...g LC and IC methods, especially those including sa...
RF-5301 Fluorescence Spectrophotometer from Shimadzu
Biology Products: